ADAM19
ADAM19[edit | edit source]
ADAM19 (A Disintegrin and Metalloproteinase domain-containing protein 19) is a member of the ADAM family of proteins, which are characterized by their disintegrin and metalloproteinase domains. These proteins are involved in a variety of biological processes, including cell adhesion, cell fusion, and proteolysis.
Structure[edit | edit source]
ADAM19 is a type I transmembrane protein that consists of several distinct domains:
- A signal peptide that directs the nascent protein to the secretory pathway.
- A pro-domain that is cleaved to activate the protein.
- A metalloproteinase domain that contains the catalytic site for proteolytic activity.
- A disintegrin domain that is involved in cell-cell and cell-matrix interactions.
- A cysteine-rich domain and an EGF-like domain that may play roles in protein-protein interactions.
- A transmembrane domain that anchors the protein in the cell membrane.
- A cytoplasmic tail that may be involved in intracellular signaling.
Function[edit | edit source]
ADAM19 is involved in several physiological processes:
- **Proteolysis**: It cleaves and processes various substrates, including growth factors, cytokines, and cell surface receptors.
- **Cell Adhesion and Migration**: The disintegrin domain of ADAM19 can interact with integrins, influencing cell adhesion and migration.
- **Development**: ADAM19 plays a role in cardiac and neural development, as well as in the formation of the skeletal system.
Clinical Significance[edit | edit source]
Mutations or dysregulation of ADAM19 have been implicated in various diseases:
- **Cancer**: Altered expression of ADAM19 has been observed in certain types of cancer, where it may influence tumor progression and metastasis.
- **Cardiovascular Diseases**: ADAM19 is involved in heart development, and its dysregulation can contribute to congenital heart defects.
- **Neurological Disorders**: Given its role in neural development, ADAM19 may be involved in certain neurological conditions.
Research[edit | edit source]
Ongoing research is focused on understanding the precise mechanisms by which ADAM19 contributes to these processes and its potential as a therapeutic target.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD